THE COSTS OF REGIONAL ANESTHESIA WITH THE USE OF LEVOBUPIVACAINE, RACEMIC BUPIVACAINE AND ROPIVACAINE

by G. E. Ulrikh, A. V. Rudakova
Published 2017-03-01

THE EFFICACY OF THE COSTS ON SEVERE RESPIRATORY SYNCYTIAL INFECTION PREVENTION WITH PALIVIZUMAB IN PRETERM INFANTS

by A. V. Rudakova, I. V. Babachenko, V. B. Rovnyi, A. N. Uskov, Yu. V. Lobzin
Published 2012-07-01

Comparative analysis of laparoscopic and laparotomic panhysterectomy costs in patients with early stage endometrial cancer

by O. A. Smirnova, A. M. Belyaev, I. V. Berlev, A. V. Rudakova, A. P. Karitskiy
Published 2017-05-01

INFLUENZA VACCINATION OF CHILDREN OF PRESCHOOL AGE IN THE RUSSIAN FEDERATION: COST-EFFECTIVENESS OF QUADRIVALENT VACCINE

by A. V. Rudakova, D. M. Danilenko, D. A. Lioznov, L. S. Karpova, S. M. Kharit, E. V. Mikitenko, A. N. Uskov, A. S. Kolbin, L. N. Konovalova, Yu. V. Lobzin
Published 2019-03-01

Cost-effectiveness of vaccination against pneumococcal infection of adults at risk within the federal and regional programs

by A. V. Rudakova, N. I. Briko, Yu. V. Lobzin, L. S. Namazova-Baranova, O. M. Drapkina, S. N. Avdeev, L. Yu. Drozdova, G. L. Ignatova, I. S. Koroleva, V. A. Korshunov, M. P. Kostinov
Published 2019-12-01

Cost-effectiveness of antiviral therapy in treatment-naive patients with chronic hepatitis C (genotype 1)

by A. V. Rudakova, D. A. Gusev, A. N. Uskov, L. N. Konovalova, Yu. V. Lobzin
Published 2017-06-01

COST-EFFICACY ANALYSIS OF GEFITINIB EFFICACY IN PATIENTS WITH NON OPERABLE NON SMALL CELL LUNG CANCER

by S. A. Protsenko, A. V. Rudakova, F. V. Moiseyenko, E. V. Levchenko, D. E. Matsko, A. О. Ivantsov, I. I. Semenov, A. G. Ievleva, N. V. Mitushkina, A. V. Togo, A. V. Novik, E. N. Imyanitov, V. M. Moiseyenko
Published 2017-01-01

Cost-effectiveness of abiraterone treatment in patients with castration-resistant prostate cancer who previously received docetaxel therapy

by A. V. Rudakova, D. O. Meshkov, S. V. Mishugin
Published 2014-11-01

Cost-effectiveness of abiraterone treatment in patients with castration-resistant prostate cancer who previously received docetaxel therapy

by A. V. Rudakova, D. O. Meshkov, S. V. Mishugin
Published 2014-11-01

COST-EFFECTIVENESS OF ANTIVIRAL THERAPY IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C (GENOTYPE 1) WITH VARIOUS SEVERITY OF FIBROSIS STAGE

by A. V. Rudakova, D. A. Gusev, A. N. Uskov, I. V. Shestakova, Yu. V. Lobzin
Published 2018-01-01

PROTEASE INHIBITOR NARLAPREVIR IN THERAPY OF HEPATITIS C VIRUS GENOTYPE 1 INFECTION IN TREATMENT-NAÏVE PATIENTS WITHOUT CIRRHOSIS: PHARMACOECONOMIC EVALUATION

by A. V. Rudakova, D. A. Gusev, A. N. Uskov, L. N. Konovalova, Yu. V. Lobzin
Published 2017-04-01

PHARMACOECONOMIC ASPECTS OF NICOTINE ADDICTION TREATMENT IN PATIENTS WITH ANGINA REQUIRING CARDIAC SURGERY

by A. V. Rudakova, M. S. Berezhnova
Published 2015-12-01

Сost-effectiveness of the second wave of protease inhibitors in the treatment of chronic hepatitis C (genotype 1) in patients not previously treated with antiviral drugs, and for r...

by A. V. Rudakova, D. A. Gusev, A. N. Uskov, L. N. Konovalova, Yu. V. Lobzin
Published 2016-04-01

Pharmacoeconomic aspects of recurrent / refractory chronic lymphocytic leukemia treatment

by A. V. Rudakova, E. A. Stadnik
Published 2020-04-01

PHARMACOECONOMIC ASPECTS OF NICOTINE ADDICTION TREATMENT IN PATIENTS WITH ANGINA REQUIRING CARDIAC SURGERY

by A. V. Rudakova, M. S. Berezhnova
Published 2015-12-01

ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION

by A. V. Rudakova
Published 2015-09-01

ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION

by A. V. Rudakova
Published 2015-09-01

PHARMACOECONOMIC ASPECTS OF NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY

by A. V. Rudakova, S. A. Protsenko, I. A. Koroleva
Published 2017-08-01